Literature DB >> 1696664

Differential distribution of postjunctional alpha 2 adrenoceptors in human omental small arteries.

H Nielsen1, F V Mortensen, M J Mulvany.   

Abstract

A pharmacologic characterization of the postjunctional alpha adrenoceptors of human omental small arteries was performed using a microvascular myograph. Both the alpha 1-selective agonist phenylephrine in the presence of yohimbine (0.3 microM, alpha 2-selective antagonist) and the alpha 2-selective agonist B-HT 933 in the presence of prazosin (0.3 microM, alpha 1-selective antagonist) evoked strong vasoconstriction. The responses to phenylephrine were competitively antagonized by prazosin, whereas the responses to B-HT 933 were competitively antagonized by yohimbine; the pA2-values were 9.24 and 8.34, respectively. An inverse relationship of the maximum response to B-HT 933 (r = -0.53; p less than 0.001), but not to phenylephrine or to norepinephrine (NE), against artery caliber was observed. The shifts of the NE concentration-response curves caused by yohimbine (0.1 microM) were more marked in the smaller rather than the larger vessels (r = -0.71; p less than 0.01), whereas the opposite was observed using 0.1 microM prazosin (r = 0.84; p less than 0.001). These data suggest that both alpha 1 and alpha 2 adrenoceptors are present in the human omental small arteries, but whereas postjunctional alpha 2 adrenoceptors appear to be located predominantly in the resistance arteries, postjunctional alpha 1 adrenoceptors appear to be distributed evenly along the arterial tree.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1696664     DOI: 10.1097/00005344-199007000-00006

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  1 in total

1.  Alpha-adrenergic reactivity of the microcirculation in conscious spontaneously hypertensive rats.

Authors:  H A Struijker-Boudier; M W Messing; H van Essen
Journal:  Mol Cell Biochem       Date:  1996 Apr 12-26       Impact factor: 3.396

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.